Detalhe da pesquisa
1.
HIV Diagnostics and Vaccines: It Takes Two to Tango.
J Infect Dis
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38451247
2.
Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial.
Am J Respir Crit Care Med
; 195(9): 1171-1180, 2017 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28060545
3.
Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial.
JAMA
; 315(15): 1610-23, 2016 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27092831
4.
An alternative to the adenovirus inverted terminal repeat sequence increases the viral genome replication rate and provides a selective advantage in vitro.
J Gen Virol
; 95(Pt 7): 1574-1584, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24764357
5.
Immunogenicity of 2 therapeutic mosaic HIV-1 vaccine strategies in individuals with HIV-1 on antiretroviral therapy.
NPJ Vaccines
; 9(1): 89, 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782902
6.
Genetic immunization in the lung induces potent local and systemic immune responses.
Proc Natl Acad Sci U S A
; 107(51): 22213-8, 2010 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-21135247
7.
Towards Novel HIV-1 Serodiagnostic Tests without Vaccine-Induced Seroreactivity.
Microbiol Spectr
; 11(3): e0071523, 2023 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37222611
8.
Persistence of immunological memory as a potential correlate of long-term, vaccine-induced protection against Ebola virus disease in humans.
Front Immunol
; 14: 1215302, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37727795
9.
Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge.
J Virol
; 85(9): 4222-33, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21325402
10.
Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels.
Vaccines (Basel)
; 10(8)2022 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36016151
11.
The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults.
Am J Respir Crit Care Med
; 181(12): 1407-17, 2010 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20167847
12.
Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate.
NPJ Vaccines
; 5(1): 112, 2020 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33335092
13.
Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17-22).
Lancet HIV
; 7(6): e410-e421, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32078815
14.
Adenovirally-Induced Polyfunctional T Cells Do Not Necessarily Recognize the Infected Target: Lessons from a Phase I Trial of the AERAS-402 Vaccine.
Sci Rep
; 6: 36355, 2016 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27805026
15.
Adenovirus type 35-vectored tuberculosis vaccine has an acceptable safety and tolerability profile in healthy, BCG-vaccinated, QuantiFERON(®)-TB Gold (+) Kenyan adults without evidence of tuberculosis.
Vaccine
; 34(21): 2430-2436, 2016 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27026148
16.
The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4(+) T cell counts >350 cells/mm(3).
Vaccine
; 33(15): 1890-6, 2015 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-25698492
17.
A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated Healthy Adults.
PLoS One
; 10(11): e0141687, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26529238
18.
Ad35.CS.01-RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults.
PLoS One
; 10(7): e0131571, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26148007
19.
Comparison of multiple adjuvants on the stability and immunogenicity of a clade C HIV-1 gp140 trimer.
Vaccine
; 32(18): 2109-16, 2014 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-24556505
20.
A nonhuman primate toxicology and immunogenicity study evaluating aerosol delivery of AERAS-402/Ad35 vaccine: Evidence for transient t cell responses in peripheral blood and robust sustained responses in the lungs.
Hum Vaccin Immunother
; 10(8): 2199-210, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25424923